Clinical Trials
All Clinical Trials - Page 29 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04515576Phase 1Completed
A Study of LY3493269 in Participants With Type 2 Diabetes
Dulaglutide
- NCT04311411Phase 1Completed
A Study of Tirzepatide in Overweight and Very Overweight Participants
Tirzepatide
- NCT04537624N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice
Semaglutide
- NCT04727684Phase 4Completed
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
Gonadorelin
- NCT04747392Phase 1Completed
Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults
Teriparatide
- NCT04605861Phase 3Completed
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
Liraglutide
- NCT04478708Phase 1Completed
Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity
Maridebart-Cafraglutide
- NCT04979611Phase 1Unknown
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
Exenatide
- NCT04311424Phase 1Completed
Study of Tirzepatide in Healthy Participants
Tirzepatide
- NCT04081337Phase 1Completed
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
Tirzepatide
- NCT04348175Phase 1Completed
A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
Setmelanotide
- NCT04242017Phase 2/Phase 3Recruiting
Long-term Better Than Short-term ADT With Salvage RT
Gonadorelin
- NCT04420585Phase 4Terminated
Desmopressin for Bedwetting in Children With SCD
Desmopressin
- NCT05683444EARLY_Phase 1Completed
Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial
Octreotide
- NCT05628558N/AUnknown
Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A
Desmopressin
- NCT04001231Phase 1Withdrawn
Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT04379856Phase 1/Phase 2Unknown
Proof of Concept Study in Patients With Short Bowel Syndrome
Exenatide
- NCT04504396Phase 3Completed
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
Exenatide
- NCT05294536Phase 1Completed
A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
Liraglutide
- NCT04427787Phase 2Unknown
A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET
Lanreotide
- NCT04440345Phase 1/Phase 2Completed
Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
Mazdutide
- NCT04158362Phase 3Active Not Recruiting
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer
Gonadorelin
- NCT05484193N/AUnknown
GnRH Agonist for Luteal Phase Support.
Gonadorelin
- NCT06775990N/ACompleted
Molecules Associated with Pediatric Obesity
Kisspeptin
- NCT04384081Phase 1Completed
A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2
Survodutide
- NCT04353193Phase 4Unknown
Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.
Octreotide
- NCT04255433Phase 3Completed
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Tirzepatide
- NCT04893148Phase 4Unknown
Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
Dulaglutide
- NCT04525300Phase 3Unknown
Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
Liraglutide
- NCT04329975N/ACompleted
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
Desmopressin
- NCT06099067N/ACompleted
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
Liraglutide
- NCT04387201Phase 4Completed
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
Dulaglutide
- NCT04126070Phase 2Active Not Recruiting
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
Gonadorelin
- NCT04487743Phase 3Unknown
Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
Liraglutide
- NCT04374578N/ACompleted
Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
Dulaglutide
- NCT03716115Phase 2Completed
Therapeutic Approaches to Malnutrition Enteropathy
Teduglutide
- NCT04146155Phase 4Unknown
Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
Liraglutide
- NCT04153929Phase 2Completed
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
Semaglutide
- NCT04373967Phase 3Unknown
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
Liraglutide
- NCT04504370Phase 3Completed
Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
Exenatide
- NCT03777982Phase 3Terminated
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Gonadorelin
- NCT03680053N/ATerminated
Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
Gonadorelin
- NCT04087408Phase 3Unknown
Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial
Gonadorelin
- NCT04008290Phase 4Unknown
The Effect of Liraglutide on the GIT
Liraglutide
- NCT04003519N/AWithdrawn
Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
Lanreotide
- NCT04065165Phase 3Withdrawn
Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
Lanreotide
- NCT03658213Phase 3Withdrawn
To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.
Gonadorelin
- NCT04269642Phase 2Unknown
SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
Exenatide
- NCT04545931Phase 4Unknown
Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT04287179Phase 3Withdrawn
SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Semaglutide